company background image
EVH

Evolent Health NYSE:EVH Stock Report

Last Price

US$28.62

Market Cap

US$2.6b

7D

-4.8%

1Y

51.5%

Updated

24 May, 2022

Data

Company Financials +
EVH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends0/6

EVH Stock Overview

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States.

Evolent Health Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Evolent Health
Historical stock prices
Current Share PriceUS$28.62
52 Week HighUS$34.60
52 Week LowUS$18.33
Beta2.07
1 Month Change2.14%
3 Month Change28.86%
1 Year Change51.51%
3 Year Change102.26%
5 Year Change26.08%
Change since IPO51.75%

Recent News & Updates

May 04
Is Evolent Health (NYSE:EVH) Using Too Much Debt?

Is Evolent Health (NYSE:EVH) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

EVHUS Healthcare ServicesUS Market
7D-4.8%-2.1%-4.0%
1Y51.5%-40.1%-13.2%

Return vs Industry: EVH exceeded the US Healthcare Services industry which returned -38.1% over the past year.

Return vs Market: EVH exceeded the US Market which returned -12.3% over the past year.

Price Volatility

Is EVH's price volatile compared to industry and market?
EVH volatility
EVH Average Weekly Movement6.2%
Healthcare Services Industry Average Movement12.5%
Market Average Movement7.8%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market2.9%

Stable Share Price: EVH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: EVH's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20113,500Seth Blackleyhttps://www.evolenthealth.com

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.

Evolent Health Fundamentals Summary

How do Evolent Health's earnings and revenue compare to its market cap?
EVH fundamental statistics
Market CapUS$2.62b
Earnings (TTM)-US$24.44m
Revenue (TTM)US$989.94m

2.6x

P/S Ratio

-107.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EVH income statement (TTM)
RevenueUS$989.94m
Cost of RevenueUS$719.46m
Gross ProfitUS$270.49m
Other ExpensesUS$294.93m
Earnings-US$24.44m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.27
Gross Margin27.32%
Net Profit Margin-2.47%
Debt/Equity Ratio46.2%

How did EVH perform over the long term?

See historical performance and comparison

Valuation

Is Evolent Health undervalued compared to its fair value and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: EVH ($28.62) is trading below our estimate of fair value ($67.84)

Significantly Below Fair Value: EVH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: EVH is unprofitable, so we can't compare its Price-To-Earnings Ratio to the US Healthcare Services industry average.

PE vs Market: EVH is unprofitable, so we can't compare its Price-To-Earnings Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EVH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EVH is overvalued based on its Price-To-Book Ratio (4.3x) compared to the US Healthcare Services industry average (2.1x).


Future Growth

How is Evolent Health forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


62.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EVH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: EVH is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: EVH's is expected to become profitable in the next 3 years.

Revenue vs Market: EVH's revenue (15.7% per year) is forecast to grow faster than the US market (7.8% per year).

High Growth Revenue: EVH's revenue (15.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: EVH's Return on Equity is forecast to be low in 3 years time (6.3%).


Past Performance

How has Evolent Health performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-20.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EVH is currently unprofitable.

Growing Profit Margin: EVH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: EVH is unprofitable, and losses have increased over the past 5 years at a rate of 20.2% per year.

Accelerating Growth: Unable to compare EVH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EVH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (9.5%).


Return on Equity

High ROE: EVH has a negative Return on Equity (-4%), as it is currently unprofitable.


Financial Health

How is Evolent Health's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: EVH's short term assets ($463.4M) exceed its short term liabilities ($382.5M).

Long Term Liabilities: EVH's short term assets ($463.4M) exceed its long term liabilities ($345.5M).


Debt to Equity History and Analysis

Debt Level: EVH's net debt to equity ratio (11.9%) is considered satisfactory.

Reducing Debt: EVH's debt to equity ratio has increased from 13.5% to 46.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable EVH has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: EVH is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 4.9% per year.


Dividend

What is Evolent Health current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate EVH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EVH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EVH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EVH's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as EVH has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.1yrs

Average management tenure


CEO

Seth Blackley (42 yo)

11.33yrs

Tenure

US$6,526,285

Compensation

Mr. Seth Barrie Blackley serves as Chief Executive Officer at Evolent Health, Inc. since October 1, 2020. He serves as President of True Health Indiana, Inc. (True Health Indiana). Mr. Blackley co-founded...


CEO Compensation Analysis

Compensation vs Market: Seth's total compensation ($USD6.53M) is about average for companies of similar size in the US market ($USD6.83M).

Compensation vs Earnings: Seth's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: EVH's management team is considered experienced (3.1 years average tenure).


Board Members

Experienced Board: EVH's board of directors are considered experienced (4.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.3%.


Top Shareholders

Company Information

Evolent Health, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Evolent Health, Inc.
  • Ticker: EVH
  • Exchange: NYSE
  • Founded: 2011
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: US$2.621b
  • Shares outstanding: 91.59m
  • Website: https://www.evolenthealth.com

Number of Employees


Location

  • Evolent Health, Inc.
  • 800 North Glebe Road
  • Suite 500
  • Arlington
  • Virginia
  • 22203
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/24 00:00
End of Day Share Price2022/05/24 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.